-
-
-
-
-
-
-
Azitra denies report of $44 million securities offering
-
-
-
-
-
-
-
Azitra, Inc. (AZTR) PT Lowered to $2 at Maxim Group
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
-
-
-
-
-
436,018 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

